Key Events

CenterImage

  • 11/1/11 Highland begins brain stimulation trial for the treatment of Osteoarthritis pain.

  • 7/1/11 Highland receives 510K clearance with the FDA for its ESStim 101 product.

  • 4/1/11 Highland submits 510K with the FDA for its ESStim 101 product.

  • 1/1/11 Highland clears IRB at Spaulding Rehabilitation Hospital for the treatment of Osteoarthritis pain.

  • 11/1/10 Highland wins NIH/IRS QTDP development grant.

  • 8/1/10 Bill Edelman joins Highland Instruments as the acting CEO and COB.

  • 3/1/10 Highland completes preclinical research focused on validating its technique through electrophysiology measures.

  • 12/1/09 Highland expands its business advisory board.

  • 8/1/09 Highland begins Phase I SBIR work funded by DARPA.

  • 3/1/09 Highland successfully completes first-in-man trial.

  • 1/1/09 Highland completes second angel funding round.

  • 10/1/08 Highland wins National Institutes of Health National Institute of Neurological Disease and Stroke Phase I SBIR for developing novel technology for deep brain stimulation.

archives and/or further information request